Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist

Gastrin releasing-peptide (GRP) is a potent growth factor in many malignancies. Benign prostatic hyperplasia (BPH) is a progressive age-related proliferation of glandular and stromal tissues; various growth factors and inflammatory processes are involved in its pathogenesis. We have demonstrated tha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rick, Ferenc G., Abi-Chaker, Andrew, Szalontay, Luca, Perez, Roberto, Jaszberenyi, Miklos, Jayakumar, Arumugam R., Shamaladevi, Nagarajarao, Szepeshazi, Karoly, Vidaurre, Irving, Halmos, Gabor, Krishan, Awtar, Block, Norman L., Schally, Andrew V.
Formato: Artigo
Lenguaje:Inglês
Publicado: National Academy of Sciences 2013
Materias:
Biological Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3574942/
https://ncbi.nlm.nih.gov/pubmed/23359692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1222355110
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares